Cidara Therapeutics, Inc.CDTXNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% below average
Average (39q)
40.28%
Historical baseline
Range
High:1264.74%
Low:-100.00%
Volatility
3388.0%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | -68.96% |
| Q1 2024 | -94.47% |
| Q4 2023 | 90.77% |
| Q3 2023 | 81.08% |
| Q2 2023 | -80.50% |
| Q1 2023 | 155.48% |
| Q4 2022 | -74.92% |
| Q3 2022 | 555.47% |
| Q2 2022 | -12.56% |
| Q1 2022 | -1.61% |
| Q4 2021 | 2.11% |
| Q3 2021 | -78.47% |
| Q2 2021 | 1264.74% |
| Q1 2021 | -35.43% |
| Q4 2020 | 54.35% |
| Q3 2020 | -28.77% |
| Q2 2020 | 34.07% |
| Q1 2020 | 39.39% |
| Q4 2019 | -90.50% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |